These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32973325)

  • 1. α-Galactosylceramide and its analog OCH differentially affect the pathogenesis of ISO-induced cardiac injury in mice.
    Chen X; Liu J; Liu J; Wang WJ; Lai WJ; Li SH; Deng YF; Zhou JZ; Yang SQ; Liu Y; Shou WN; Cao DY; Li XH
    Acta Pharmacol Sin; 2020 Nov; 41(11):1416-1426. PubMed ID: 32973325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of invariant natural killer T cells by α-galactosylceramide ameliorates myocardial ischemia/reperfusion injury in mice.
    Homma T; Kinugawa S; Takahashi M; Sobirin MA; Saito A; Fukushima A; Suga T; Takada S; Kadoguchi T; Masaki Y; Furihata T; Taniguchi M; Nakayama T; Ishimori N; Iwabuchi K; Tsutsui H
    J Mol Cell Cardiol; 2013 Sep; 62():179-88. PubMed ID: 23774048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Th1/Th2 cytokine polarity induced by invariant NKT cells on the incidence of pregnancy loss in mice.
    Hoya M; Nagamatsu T; Fujii T; Schust DJ; Oda H; Akiba N; Iriyama T; Kawana K; Osuga Y; Fujii T
    Am J Reprod Immunol; 2018 Mar; 79(3):. PubMed ID: 29363849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing and curing citrulline-induced autoimmune arthritis in a humanized mouse model using a Th2-polarizing iNKT cell agonist.
    Walker KM; Rytelewski M; Mazzuca DM; Meilleur SA; Mannik LA; Yue D; Brintnell WC; Welch I; Cairns E; Haeryfar SM
    Immunol Cell Biol; 2012 Jul; 90(6):630-9. PubMed ID: 21912419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. scRNA-Seq and imaging mass cytometry analyses unveil iNKT cells-mediated anti-tumor immunity in pancreatic cancer liver metastasis.
    Yi Q; Wang J; Liu T; Yao Y; Loveless I; Subedi K; Toor J; Adrianto I; Xiao H; Chen B; Crawford HC; Fang D; Zhou L; Mi QS
    Cancer Lett; 2023 May; 561():216149. PubMed ID: 36990268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cells decrease invariant natural killer T cell-mediated pregnancy loss in mice.
    Li L; Tu J; Jiang Y; Zhou J; Schust DJ
    Mucosal Immunol; 2017 May; 10(3):613-623. PubMed ID: 27706127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes.
    Gehrmann U; Hiltbrunner S; Georgoudaki AM; Karlsson MC; Näslund TI; Gabrielsson S
    Cancer Res; 2013 Jul; 73(13):3865-76. PubMed ID: 23658368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective stimulation of invariant natural killer T cells by oligomannose-coated liposomes.
    Ishii M; Kojima N
    Int Immunopharmacol; 2013 Apr; 15(4):685-92. PubMed ID: 23535021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano spray dryer for vectorizing α-galactosylceramide in polymeric nanoparticles: A single step process to enhance invariant Natural Killer T lymphocyte responses.
    Gonzatti MB; Sousa MEP; Tunissi AS; Mortara RA; de Oliveira AM; Pereira Cerize NN; Keller AC
    Int J Pharm; 2019 Jun; 565():123-132. PubMed ID: 31075434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serpinb1a Is Dispensable for the Development and Cytokine Response of Invariant Natural Killer T Cell Subsets.
    Leborgne NGF; Taddeo A; Freigang S; Benarafa C
    Front Immunol; 2020; 11():562587. PubMed ID: 33262755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfatide inhibits α-galactosylceramide presentation by dendritic cells.
    Kanamori M; Tasumi Y; Iyoda T; Ushida M; Inaba K
    Int Immunol; 2012 Feb; 24(2):129-36. PubMed ID: 22247226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
    Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
    Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of invariant natural killer T-cell anergy induction through intradermal delivery of alpha-galactosylceramide.
    Bontkes HJ; Moreno M; Hangalapura B; Lindenberg JJ; de Groot J; Lougheed S; van der Vliet HJ; van den Eertwegh AJ; de Gruijl TD; von Blomberg BM; Scheper RJ
    Clin Immunol; 2010 Sep; 136(3):364-74. PubMed ID: 20570567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride.
    Park O; Jeong WI; Wang L; Wang H; Lian ZX; Gershwin ME; Gao B
    Hepatology; 2009 May; 49(5):1683-94. PubMed ID: 19205035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of natural killer T cells ameliorates postinfarct cardiac remodeling and failure in mice.
    Sobirin MA; Kinugawa S; Takahashi M; Fukushima A; Homma T; Ono T; Hirabayashi K; Suga T; Azalia P; Takada S; Taniguchi M; Nakayama T; Ishimori N; Iwabuchi K; Tsutsui H
    Circ Res; 2012 Sep; 111(8):1037-47. PubMed ID: 22887770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion or Suppression of Murine Intestinal Polyp Development by iNKT Cell Directed Immunotherapy.
    Wang Y; Sedimbi SK; Löfbom L; Besra GS; Porcelli SA; Cardell SL
    Front Immunol; 2019; 10():352. PubMed ID: 30881361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invariant NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulation.
    Iyoda T; Ushida M; Kimura Y; Minamino K; Hayuka A; Yokohata S; Ehara H; Inaba K
    Int Immunol; 2010 Nov; 22(11):905-13. PubMed ID: 21118907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD1d-dependent natural killer T cells attenuate angiotensin II-induced cardiac remodelling via IL-10 signalling in mice.
    Wang HX; Li WJ; Hou CL; Lai S; Zhang YL; Tian C; Yang H; Du J; Li HH
    Cardiovasc Res; 2019 Jan; 115(1):83-93. PubMed ID: 29939225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCR-dependent and -independent activation underlie liver-specific regulation of NKT cells.
    Subleski JJ; Hall VL; Wolfe TB; Scarzello AJ; Weiss JM; Chan T; Hodge DL; Back TC; Ortaldo JR; Wiltrout RH
    J Immunol; 2011 Jan; 186(2):838-47. PubMed ID: 21148802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses.
    Corgnac S; Perret R; Derré L; Zhang L; Stirnemann K; Zauderer M; Speiser DE; Mach JP; Romero P; Donda A
    Cancer Immunol Immunother; 2013 Apr; 62(4):747-60. PubMed ID: 23242316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.